Dimeric camptothecin-loaded RGD-modified targeted cationic polypeptide-based micelles with high drug loading capacity and redox-responsive drug release capability
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dimeric camptothecin-loaded RGD-modified targeted cationic polypeptide-based micelles with high drug loading capacity and redox-responsive drug release capability
Authors
Keywords
-
Journal
Biomaterials Science
Volume 5, Issue 12, Pages 2501-2510
Publisher
Royal Society of Chemistry (RSC)
Online
2017-10-24
DOI
10.1039/c7bm00791d
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safe approaches for camptothecin delivery: Structural analogues and nanomedicines
- (2017) Pablo Botella et al. JOURNAL OF CONTROLLED RELEASE
- Polyamino acid-based gemcitabine nanocarriers for targeted intracellular drug delivery
- (2017) Wenzhuo Teng et al. Polymer Chemistry
- Ultrasensitive pH Triggered Charge/Size Dual-Rebound Gene Delivery System
- (2016) Xiuwen Guan et al. NANO LETTERS
- Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release
- (2015) Hua Wang et al. CHEMICAL COMMUNICATIONS
- Dimeric Drug Polymeric Nanoparticles with Exceptionally High Drug Loading and Quantitative Loading Efficiency
- (2015) Kaimin Cai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Perspectives on Biologically Active Camptothecin Derivatives
- (2015) Ying-Qian Liu et al. MEDICINAL RESEARCH REVIEWS
- Uptake and transfection efficiency of PEGylated cationic liposome–DNA complexes with and without RGD-tagging
- (2014) Ramsey N. Majzoub et al. BIOMATERIALS
- Polymeric nanomicelles for sustained delivery of anti-cancer drugs
- (2014) Roubeena Jeetah et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- A hydrazone crosslinked zwitterionic polypeptide nanogel as a platform for controlled drug delivery
- (2014) Caicai Lu et al. RSC Advances
- Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy
- (2013) Cuifang Zheng et al. BIOMATERIALS
- Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells
- (2013) Claudia Y. Acevedo-Morantes et al. DRUG DELIVERY
- pH-responsive zwitterionic copolypeptides as charge conversional shielding system for gene carriers
- (2013) Huayu Tian et al. JOURNAL OF CONTROLLED RELEASE
- Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications
- (2012) Emanuel Fleige et al. ADVANCED DRUG DELIVERY REVIEWS
- Polymeric micelles drug delivery system in oncology
- (2012) Jian Gong et al. JOURNAL OF CONTROLLED RELEASE
- A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: A strategy for overcoming the PEG dilemma
- (2010) Hiroto Hatakeyama et al. ADVANCED DRUG DELIVERY REVIEWS
- Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect
- (2010) Yasuhiro Matsumura ADVANCED DRUG DELIVERY REVIEWS
- Cancer Therapies Utilizing the Camptothecins: A Review of thein VivoLiterature
- (2010) Vincent J. Venditto et al. MOLECULAR PHARMACEUTICS
- Preclinical and clinical studies of anticancer agent-incorporating polymer micelles
- (2009) Yasuhiro Matsumura et al. CANCER SCIENCE
- Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin
- (2008) Yan Gao et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
- (2008) E. A. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More